Related Experiment Video
Updated: Oct 23, 2025
05:02
Comparing Bibliometric Analysis Using PubMed, Scopus, and Web of Science Databases
Published on: October 24, 2019
32.5K
Recommendations to improve pharmacy practice research in the Middle Eastern Arab countries
Daneh Obaid1, Faris El-Dahiyat2, Zaheer-Ud-Din Babar3
1College of Pharmacy, Al Ain University, P.O Box 64141, Al Ain, UAE.
Journal of Pharmaceutical Policy and Practice
|August 21, 2021
Summary
Pharmacy practice research is vital for evidence-based patient care. Recommendations focus on national research priorities, fostering a research culture, and promoting applied studies in Middle Eastern Arab Countries.
Area of Science:
- Pharmacy Practice Research
- Health Services Research
- Evidence-Based Practice
Background:
- Expansion of pharmacist-led services necessitates evidence on necessity, efficacy, and cost.
- Evidence-based practice is essential for optimal patient health outcomes.
- Pharmacy practice research is key to generating this evidence.
Discussion:
- A systematic literature review was conducted across 12 Middle Eastern Arab Countries.
- The review identified critical areas for advancing pharmacy practice research in the region.
- Commentary highlights the importance of research in validating and expanding clinical pharmacy services.
Key Insights:
- Health authorities should identify national research priorities.
- A strong research culture needs nurturing among academics and practitioners.
- Research should shift towards applied, interventional, and implementation studies.
Outlook:
- Implementing these recommendations can enhance the impact of pharmacy practice research.
- Strengthened research will support the evidence base for expanded pharmacist roles.
- This work aims to guide future research agendas in Middle Eastern Arab Countries.
Related Concept Videos
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
35
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
35
01:15Drug Dosing: Geriatric Patients
46
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
46
01:19Pharmacovigilance
1.2K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.2K
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
41
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
41
01:28Dosage Regimens: Designs and Approaches
62
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
62
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
34
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
34